Liquid biopsy in cancer: current status, challenges and future prospects
Liwei Ma, Huiling Guo, Yunxiang Zhao, Zhibo Liu, Chenran Wang, Jiahao Bu, Ting Sun, Jianwei Wei · 2024
Read Liquid biopsy in cancer: current status, challenges and future prospects by Liwei Ma, Huiling Guo, Yunxiang Zhao, Zhibo Liu, Chenran Wang, Jiahao Bu, Ting Sun, Jianwei Wei (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11609310.txt.
Description
Liwei Ma and seven co-authors review blood based cancer tests in a 2024 paper. Cutting tissue remains the standard way to diagnose tumors. It is accurate but invasive and sometimes slow. A liquid biopsy reads cancer traces floating in blood instead.
Those traces include whole tumor cells and scraps of tumor DNA. Small sacs shed by cells and tiny RNA pieces also count. The review walks through use in several common cancers. It weighs speed and comfort gains against lab hurdles. Test results can guide treatment choice and track its effect. The authors see the method moving toward routine care as detection improves.
Catalog record
| CREATOR | Liwei Ma, Huiling Guo, Yunxiang Zhao, Zhibo Liu, Chenran Wang, Jiahao Bu, Ting Sun, Jianwei Wei |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 147 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |